Sleep Disorders Treatment in Philadelphia, PA: Evaluate It, Don't Just Sleep On It

Sleep is one of the most upstream interventions in primary care. It affects metabolic health, cardiovascular risk, cognitive function, mood, immune function, and most longevity markers. Yet sleep evaluation in standard Philadelphia primary care is usually limited to "are you sleeping?" followed by a prescription for Ambien. This page is how Fishtown Medicine actually evaluates and treats sleep disorders.

The major sleep conditions we evaluate

Obstructive sleep apnea (OSA). The most consequential and most under-recognized. Presents with snoring, witnessed apneas, waking unrefreshed, fatigue, headaches, hypertension, and atrial fibrillation - but often presents without prominent snoring, especially in women and lean patients. Home sleep studies are widely available and accurate for screening. Treatment is CPAP, oral appliances, sometimes positional therapy or surgery. Insomnia. Difficulty falling asleep, staying asleep, or waking unrefreshed. The right first-line treatment is cognitive behavioral therapy for insomnia (CBT-I), not medications. Medications have a role but are usually overused as a first move. Restless legs syndrome (RLS). Uncomfortable leg sensations relieved by movement, worse in evening. Frequently associated with iron deficiency (ferritin under 75 is often clinically relevant). Treatment includes iron replacement, pregabalin or gabapentin, sometimes dopamine agonists with careful dosing. REM sleep behavior disorder. Acting out dreams during REM sleep. Important to recognize because it is associated with future neurodegenerative disease (Parkinson's, Lewy body dementia). Requires sleep medicine evaluation. Circadian rhythm disorders. Delayed sleep phase, advanced sleep phase, shift work disorder. Treatment includes light therapy, melatonin timing, and sleep schedule management. Narcolepsy. Excessive daytime sleepiness with cataplexy or sleep-onset REM. Requires specialty evaluation. Parasomnias. Sleep walking, night terrors, sleep eating. Usually require sleep medicine input. Inadequate sleep duration or quality from lifestyle. Often the most common cause of "I'm tired" in clinic. Caffeine timing, alcohol, screens, schedule consistency.

A real sleep evaluation

For a patient presenting with sleep concerns or fatigue, we cover:

• Sleep history: bedtime, wake time, latency, awakenings, dreams, restlessness, snoring, witnessed apneas, daytime sleepiness, naps.
• Medical history with attention to depression, anxiety, GERD, nasal congestion, heart disease, hypertension, atrial fibrillation, hypothyroidism, urinary frequency.
• Medications and substance use.
• Caffeine and alcohol patterns.
• Stress and recent life changes.
• Iron studies if RLS is on the differential.
• Home sleep study if OSA is suspected (most patients with fatigue, hypertension, atrial fibrillation, or relevant features should be screened).
• Polysomnography (in-lab study) for complex cases or when home study is inconclusive.

Sleep apnea treatment

CPAP remains the standard for moderate to severe OSA. Compliance can be a challenge; we work with patients on mask fit, pressure settings, humidification, and other adjustments. Oral appliances are reasonable for mild to moderate OSA and for patients who cannot tolerate CPAP. Surgery (UPPP, hypoglossal nerve stimulator) is reserved for specific anatomy and failed conservative treatment.

Hypoglossal nerve stimulation (Inspire device) has become a reasonable option for select patients with moderate to severe OSA who cannot tolerate CPAP. It requires sleep medicine and ENT coordination.

Insomnia treatment

CBT-I is the first-line treatment with the best long-term evidence. It involves sleep restriction, stimulus control, cognitive restructuring around sleep, and sleep hygiene. Several Philadelphia therapists offer CBT-I, and there are also app-based programs (Somryst, SleepIO) with reasonable evidence. Medications have a role but are usually short-term:

• Trazodone at low doses (25-100 mg) is commonly used and reasonably safe long-term.
• Doxepin at low doses (3-6 mg) is FDA-approved for insomnia.
• Z-drugs (zolpidem, eszopiclone) have evidence but tolerance and dependence are concerns.
• Dual orexin receptor antagonists (suvorexant, lemborexant, daridorexant) are newer options.
• Melatonin has modest effects for circadian issues; less effect for general insomnia.
• Benzodiazepines are usually avoided as first-line for chronic insomnia.

How sleep care works at Fishtown Medicine

First visit is 90 minutes. We build the picture and decide whether a home sleep study is warranted (often yes if there are any cardiometabolic features or fatigue). We start non-pharmacologic measures immediately and discuss CBT-I for insomnia. Follow-up at 4-6 weeks for results review and treatment planning. Then at 1-3 month intervals as we refine. We coordinate with sleep medicine, ENT, and dental sleep specialists when needed. Multiple Philadelphia sleep centers offer home sleep studies and in-lab polysomnography.

What it costs

Membership is $250/month, $685/quarter, $2,500/year. All visits and ongoing management are included. Home sleep studies are typically covered by insurance with appropriate indication; self-pay pricing is usually $200-400. CPAP equipment is covered by insurance for documented OSA. CBT-I is sometimes covered, sometimes self-pay.

Key Takeaways

• Sleep dysfunction is upstream of most other primary care problems.
• Sleep apnea is common, consequential, and often undiagnosed in women and lean patients.
• CBT-I is the right first-line for chronic insomnia, not medications.
• Home sleep studies are widely available and accurate for screening.
• Fishtown Medicine evaluates and manages most sleep conditions in primary care.

Related Services and Reading

• Chronic Fatigue Treatment in Philadelphia
• Brain Fog Treatment in Philadelphia
• Long COVID Care in Philadelphia
• Metabolic Health in Philadelphia
• Direct Primary Care in Philadelphia

---